Klassen Preston

Regulus Therapeutics Inc. · President & Head of R & D

Klassen Preston is listed in public filings as director, officer: President & Head of R & D. This Klassen Preston insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Regulus Therapeutics Inc. (RGLS). Investors use Klassen Preston's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.

Latest Trades

CompanyValueActionPriceCurrent Price
Regulus Therapeutics Inc.RGLS$96k12k sharesBuyJun 3, 2025$7.99--